|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:acquisition
|
Various smaller pharmaceutical companies
|
|
gptkbp:advertising
|
Television and print media
|
|
gptkbp:awards
|
Industry recognition
|
|
gptkbp:benefits
|
Comprehensive benefits package
|
|
gptkbp:brand_recognition
|
Strong in the industry
|
|
gptkbp:business_model
|
B2 B and B2 C
|
|
gptkbp:clinical_trial
|
Ongoing
Partnerships with universities
|
|
gptkbp:community_engagement
|
Local health fairs
|
|
gptkbp:community_support
|
Local charities
|
|
gptkbp:competitors
|
Other pharmaceutical companies
|
|
gptkbp:controversy
|
Ethical concerns regarding drug testing
|
|
gptkbp:cultural_diversity
|
Commitment to diversity
|
|
gptkbp:customer_base
|
Hospitals and clinics
|
|
gptkbp:employees
|
Confidential
|
|
gptkbp:financial_performance
|
Confidential
|
|
gptkbp:founded
|
1960s
|
|
gptkbp:founded_by
|
gptkb:Mikkos_Cassadine
|
|
gptkbp:future_plans
|
Expansion into new markets
|
|
gptkbp:has_culture
|
Innovative and competitive
|
|
gptkbp:headquarters
|
gptkb:Port_Charles,_New_York
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Cassadine Pharmaceuticals
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:invention
|
Numerous pharmaceutical patents
|
|
gptkbp:investment
|
Confidential
Biotechnology startups
|
|
gptkbp:key_people
|
gptkb:Victor_Cassadine
|
|
gptkbp:legal_issue
|
Litigation regarding patents
|
|
gptkbp:market
|
Extensive
|
|
gptkbp:market_position
|
Global
|
|
gptkbp:marketing_strategy
|
Aggressive marketing
|
|
gptkbp:notable_person
|
gptkb:Helena_Cassadine
|
|
gptkbp:operating_countries
|
gptkb:Yes
|
|
gptkbp:parent_company
|
gptkb:Cassadine_Enterprises
|
|
gptkbp:partnerships
|
gptkb:Yes
Various healthcare organizations
|
|
gptkbp:philanthropy
|
Health initiatives in Port Charles
|
|
gptkbp:product
|
Continuous
|
|
gptkbp:product_line
|
Prescription drugs
|
|
gptkbp:products
|
Medications
|
|
gptkbp:provides_guidance_on
|
Followed by healthcare providers
|
|
gptkbp:recalls
|
Occasional
|
|
gptkbp:regulatory_compliance
|
FDA regulations
|
|
gptkbp:research_and_development
|
Significant investment
|
|
gptkbp:research_focus
|
Innovative drug development
|
|
gptkbp:revenue
|
Confidential
|
|
gptkbp:safety_measures
|
High standards
|
|
gptkbp:side_effect
|
Significant in the region
|
|
gptkbp:social_responsibility
|
Health and wellness programs
|
|
gptkbp:stock_symbol
|
Not publicly traded
|
|
gptkbp:strategic_goals
|
Long-term vision
|
|
gptkbp:subsidiaries
|
gptkb:Cassadine_Medical
|
|
gptkbp:supply_chain
|
Global suppliers
|
|
gptkbp:sustainability_initiatives
|
Environmental responsibility programs
|
|
gptkbp:training
|
Ongoing professional development
|
|
gptkbp:uses_technology
|
Advanced research technologies
|
|
gptkbp:website
|
www.cassadinepharmaceuticals.com
|
|
gptkbp:bfsParent
|
gptkb:Cassadine_Enterprises
|
|
gptkbp:bfsLayer
|
6
|